Gynaecological cancer in Australia

Gynaecological cancer incorporates ICD-10 cancer codes C51 (malignant neoplasm of vulva), C52 (malignant neoplasm of vagina), C53 (malignant neoplasm of cervix), C54 (malignant neoplasm of corpus uteri), C55 (malignant neoplasm of uterus, part unspecified), C56 (malignant neoplasm of ovary), C57 (malignant neoplasm of other and unspecified female genital organs) and C58 (malignant neoplasm of placenta).

New cases of gynaecological cancer

In 2013, there were 5,336 new cases of gynaecological cancer diagnosed in Australia. In 2017, it is estimated that 6,073 new cases of gynaecological cancer will be diagnosed in Australia.

In 2013, the age-standardised incidence rate was 40 new cases per 100,000 females. In 2017, it is estimated that the age-standardised incidence rate will be 42 cases per 100,000 females. The incidence rate for gynaecological cancer is expected to generally increase with age.

In 2017, it is estimated that the risk of a female being diagnosed with gynaecological cancer by her 85th birthday will be 1 in 21.

The number of new cases of gynaecological cancer diagnosed increased from 2,950 in 1982 to 5,336 in 2013. Over the same period, the age-standardised incidence rate decreased from 44 cases per 100,000 females in 1982 to 40 cases per 100,000 females in 2013.

Deaths from gynaecological cancer

In 2014, there were 1,838 deaths from gynaecological cancer in Australia. In 2017, it is estimated that this will decrease to 1,769 deaths.

In 2014, the age-standardised mortality rate was 13 deaths per 100,000 females. In 2017, it is estimated that the age-standardised mortality rate will be 11 deaths per 100,000 females. The mortality rate for gynaecological cancer is expected to generally increase with age.

In 2017, it is estimated that the risk of a female dying from gynaecological cancer by her 85th birthday will be 1 in 66.

The number of deaths from gynaecological cancer increased from 1,120 in 1968 to 1,838 in 2014. Over the same period, the age-standardised mortality rate decreased from 23 deaths per 100,000 females in 1968 to 13 deaths per 100,000 females in 2014.

Estimated age-specific incidence and mortality rates for gynaecological cancer, females, 2017

This line chart presents the estimated age-specific incidence (solid line) and mortality (dashed line) rates of colorectal cancer for males (blue), females (purple) and persons (green) in 2017. The age-specific incidence and mortality rates are shown on the primary (left) y-axis, with 5-year age groups from ages 0–4 to 85+ shown on the x-axis.

Source: AIHW analysis of the Australian Cancer Database and AIHW National Mortality Dataset (see Cancer compendium data source table 1).

Age-standardised incidence rates for gynaecological cancer 1982–2013 and age-standardised mortality rates for gynaecological cancer 1968–2014, females

This line chart presents the estimated age-standardised incidence (solid line) and mortality (dashed line) rates (per 100,000) of gynaecological cancer for females over the period 1982–2013 for incidence and 1968–2014 for mortality. The age standardised incidence and mortality rates, expressed per 100,000 persons, are shown on the primary (left) y-axis. Years from 1968 to 2014 are presented on the x-axis.

Source: AIHW analysis of the Australian Cancer Database and AIHW National Mortality Dataset (see Cancer compendium data source table 2).

Survival from gynaecological cancer

In 2009–2013 in Australia, females diagnosed with gynaecological cancer had a 69% chance of surviving for 5 years compared to their counterparts in the general Australian population.

Between 1984–1988 and 2009–2013, 5-year relative survival from gynaecological cancer improved from 61% to 69%.

5-year relative survival from gynaecological cancer, 1984–1988 to 2009–2013

This line chart presents 5-year relative survival at diagnosis for gynaecological cancer in females over the period 1984–1988 to 2009–2013. The percentage of survival is presented on the y axis.

Source: AIHW analysis of the Australian Cancer Database (see Cancer compendium data source table 3).

Survivorship population for gynaecological cancer 

The survivorship population is measured using prevalence data. Prevalence refers to the number of people alive who have previously been diagnosed with gynaecological cancer.

The prevalence for 1, 5 and 31 years given below are the number of people living with gynaecological cancer at the end of 2012 who had been diagnosed in the preceding 1, 5 and 31 years respectively. 

At the end of 2012, there were 4,670 females living who had been diagnosed with gynaecological cancer that year, 18,469 females who had been diagnosed with gynaecological cancer in the previous 5 years (from 2008 to 2012) and 56,867 females who had been diagnosed with gynaecological cancer in the previous 31 years (from 1982 to 2012).

More information on gynaecological cancers from Cancer Australia